Considering trestolone acetate (MENT)? This experimental steroid promises extreme potency with fewer side effects. But limited research makes it high-risk. Here’s what’s actually known.

You’ve heard MENT is the future of steroids. Ten times more anabolic than testosterone. Fewer side effects than other compounds.

You’re intrigued by the potential but uncertain about safety, proper dosing, and whether the benefits justify using an experimental drug with limited human data.

You’ve been told:

• “MENT is like tren + deca + test combined”
• “10x more anabolic than testosterone”
• “Fewer side effects than traditional steroids”
• “The perfect steroid finally exists”

Some claims have theoretical basis, but heavily overstated. The truth: Trestolone acetate (MENT, 7α-methyl-19-nortestosterone) is a synthetic 19-nor steroid with extremely high anabolic potency (studies suggest 10x testosterone), designed originally for male contraception and TRT research in 1960s but abandoned for decades. Recently resurrected by underground labs despite remaining experimental. Typical use: 25-50mg daily (175-350mg weekly) due to short acetate ester. Promises: Massive muscle gains with less androgenic activity in prostate. Reality: Still causes gynecomastia (aromatizes heavily), water retention, complete testosterone suppression, and all standard steroid side effects. Unique risk: Very limited human safety data—long-term effects unknown.

In this comprehensive guide, I’ll explain what trestolone is (the chemical structure and history), reveal claimed benefits vs. reality (hype vs. evidence), detail typical protocols (dosing and cycles based on user reports), show all known side effects (estrogenic, androgenic, suppressive), address the safety concern (experimental status), and compare to established steroids (is the risk worth potential benefit?).

Whether you’re considering MENT or just curious about novel steroids, understanding the incomplete picture is essential.

Let’s examine trestolone acetate with scientific honesty about what’s known and unknown.

What Is Trestolone Acetate (MENT)?

The experimental compound.

The Basic Definition

What it is:

• Synthetic anabolic steroid
• Chemical name: 7α-methyl-19-nortestosterone
• Abbreviated as MENT
• Nandrolone derivative with modifications
• Experimental 19-nor steroid

What it was designed for:

• Male contraception (suppress sperm production)
• Alternative TRT option for hypogonadal men
• Research in 1960s-1970s
• Original medical purposes

Current status:

• Never approved for human use
• Research abandoned for decades
• Recently resurrected by underground labs
• No pharmaceutical production
• Experimental only

The Chemical Structure

Breaking down MENT (7α-methyl-19-nortestosterone):

M = Methyl:

• Methyl group added at 7α position
• Increases potency and oral bioavailability
• Enhances stability
• Chemical modification

E = Estra:

• Base structure similar to nandrolone
• 19-nor backbone
• Structural foundation

N = Nor:

• Absence of carbon at position 19
• Same as nandrolone (19-nortestosterone)
• 19-nor classification

T = Testosterone:

• Derived from testosterone structure
• Modified version
• Testosterone-based

The result:

• Nandrolone derivative
• Modified for increased potency
• Shares characteristics with nandrolone, testosterone, and trenbolone
• Hybrid structure

The Acetate Ester

Why acetate:

• Short ester (similar to trenbolone acetate)
• 2-3 day half-life
• Requires daily or every-other-day injection
• Rapid onset and clearance
• Fast-acting

Other esters exist:

• Trestolone decanoate (long-acting, research purposes)
• Trestolone enanthate (moderate-acting, uncommon)
• Acetate most common in UGL market
• Ester variations

Historical Context

Discovery (1960s):

• Developed as potential male contraceptive
• Extremely suppressive to sperm production
• Also explored for TRT
• Original research

Abandonment:

• Research discontinued
• Reasons unclear (possibly side effects or funding)
• Forgotten for 30+ years
• Research halt

Resurrection (2010s):

• Underground labs began producing
• Anecdotal reports from users
• Marketed as “next-generation steroid”
• No new clinical trials
• Black market revival

Current situation:

• Available only through UGLs (underground labs)
• No pharmaceutical-grade sources
• Quality and purity unknown
• No regulatory oversight
• Unregulated substance

Claimed Benefits vs. Reality

Separating hype from evidence.

Claim 1: “10x More Anabolic Than Testosterone”

The evidence:

• Early research suggested very high anabolic potency
• Some studies indicated 10x anabolic rating vs. testosterone
• Mechanism: Strong androgen receptor binding
• Theoretical basis exists

The reality:

• Rating systems don’t perfectly translate to human results
• Real-world anabolism likely less than 10x
• Individual response varies
• But definitely highly anabolic
• Potent but overstated

The comparison:

• Testosterone: Baseline (1x)
• Nandrolone: ~2-3x
• Trenbolone: ~5x
• Trestolone: Possibly 4-8x (realistic estimate)
• Very potent, exact multiplier uncertain

Claim 2: “Combines Best of Tren, Deca, and Test”

The kernel of truth:

• Structure shares features with all three
• Anabolic like trenbolone
• Joint benefits like nandrolone (possibly)
• Aromatizes like testosterone (actually a negative)
• Structural similarities

The marketing spin:

• Implies benefits of all three without downsides
• Not supported by evidence
• Still has significant side effects
• Oversimplified

The reality:

• Unique compound with own profile
• Not literally a “combination” of other steroids
• Has strengths and weaknesses
• Independent compound

Claim 3: “Fewer Side Effects Than Other Steroids”

Where this comes from:

• Lower androgenic activity in prostate (studies suggest)
• Might reduce BPH risk (theoretical)
• Less DHT-mediated effects (doesn’t convert to DHT)
• Selective tissue activity

The critical caveat:

• “Fewer” means compared to other steroids (not “few” or “safe”)
• Still causes gynecomastia (heavy aromatization)
• Still suppresses testosterone completely
• Still affects lipids and blood pressure
• Limited long-term safety data
• Relative, not absolute safety

The honest assessment:

• May have advantages in some areas (prostate)
• Has severe disadvantages in others (estrogenic effects)
• Overall side effect burden still significant
• Not a “safe steroid”

Claim 4: “Perfect for TRT and Male Contraception”

The original research:

• Designed for these purposes
• Very suppressive to spermatogenesis (contraceptive effect)
• Maintains anabolic effects (TRT potential)
• Research objectives

Why it failed clinically:

• Research abandoned before approval
• Reasons not fully public
• Likely side effect profile unsuitable
• Possibly difficulty controlling estrogen
• Clinical failure

The current reality:

• Not used medically for TRT or contraception
• Underground experimentation only
• No medical supervision available
• Not medically accepted

Typical Trestolone Acetate Cycles

User-reported protocols (not medical guidelines).

Critical Disclaimer

No established dosing:

• MENT never approved for human use
• No official medical dosing exists
• All information from user reports (anecdotal)
• High variability in responses
• Completely experimental

The risk:

• Unknown long-term effects
• Unknown optimal dosing
• Unknown maximum safe dose
• Quality control issues (UGL products)
• Proceed at own risk

Typical User Protocols

Dosing range:

• Low: 10-25mg daily (70-175mg weekly)
• Moderate: 25-50mg daily (175-350mg weekly)
• High: 50-100mg daily (350-700mg weekly)
• Wide range based on anecdotal reports

Injection frequency:

• Daily: Optimal (acetate ester, 2-3 day half-life)
• Every other day: Acceptable minimum
• Frequent injections required

Cycle duration:

• Typical: 8-12 weeks
• Some users: Continuous “TRT” use (indefinite)
• Variable duration

Example Beginner Protocol (Not Recommended)

If attempting (strongly discouraged for first-time users):

• Dose: 10-25mg daily
• Frequency: Daily injection
• Duration: 8 weeks
• Testosterone base: 100-200mg weekly (some debate if needed)
• Minimal approach

The debate:

• Does MENT require testosterone base?
• Some say yes (provides testosterone functions)
• Some say no (MENT sufficient alone)
• Unknown definitively
• Unclear

Example Intermediate Protocol

More common user approach:

• Dose: 25-50mg daily (175-350mg weekly)
• Frequency: Daily
• Duration: 8-12 weeks
• Often stacked with other compounds
• Moderate dosing

Stacking:

• MENT + testosterone (200-400mg/week)
• MENT + nandrolone
• MENT + other compounds
• Multi-compound

“TRT” Use (Extremely Experimental)

Some users report:

• Continuous low-dose use (5-15mg daily)
• As testosterone replacement
• Indefinite duration
• Unproven TRT alternative

The problems:

• No long-term safety data
• Estrogen management challenging
• Sperm production completely suppressed (fertility loss)
• Unknown cardiovascular effects long-term
• High-risk approach

Side Effects of Trestolone Acetate

Known and suspected effects.

Estrogenic Side Effects

The mechanism:

• MENT aromatizes to 7α-methylestradiol
• Different estrogen metabolite than from testosterone
• Possibly more potent
• Strong aromatization

Side Effect 1: Gynecomastia

The risk:

• Very high (possibly higher than testosterone)
• Aromatization significant
• Common problem

Management:

• Aromatase inhibitors (anastrozole, exemestane)
• May be less effective than with testosterone (different estrogen metabolite)
• Dosing unclear
• Difficult estrogen control

User reports:

• Gyno common even with AI use
• Estrogen management challenging
• Problematic

Side Effect 2: Water Retention

The mechanism:

• Estrogen-mediated sodium and water retention
• Possibly enhanced with MENT
• Significant retention

The impact:

• Bloated appearance
• Elevated blood pressure
• Weight gain (water)
• Cosmetic and health effects

Management:

• AI use (reduces but doesn’t eliminate)
• Sodium restriction
• Diuretics (dangerous without medical supervision)
• Challenging

Androgenic Side Effects

Side Effect 3: Acne

The mechanism:

• Androgenic stimulation of sebaceous glands
• Increased sebum production
• Standard androgenic effect

Likelihood:

• Moderate (less than DHT-derived steroids)
• Individual variation
• Variable

Side Effect 4: Hair Loss

The important difference:

• MENT does NOT convert to DHT
• Less hair loss than testosterone (theoretically)
• But still androgenic (can cause loss if prone)
• Reduced but not eliminated risk

Who’s affected:

• Those with MPB genetics
• Less aggressive than testosterone or DHT derivatives
• Lower risk than some steroids

Side Effect 5: Psychological Effects

The reports:

• Anxiety (some users)
• Insomnia (some users)
• Mood changes
• Neurological impact

The mechanism:

• Androgenic effects on CNS
• Estrogen fluctuations contribute
• Individual variation
• Unclear mechanism

Side Effect 6: Testosterone Suppression

The mechanism:

• Extremely suppressive (designed as male contraceptive)
• Shuts down HPT axis completely
• LH and FSH production cease
• Testicular atrophy
• Spermatogenesis stops
• Complete suppression

The timeline:

• Suppression within days
• Complete shutdown within 2 weeks
• Rapid and total

The fertility impact:

• Sperm production completely suppressed
• Designed effect (contraceptive use)
• Recovery uncertain (limited data)
• Fertility loss during use

Recovery:

• PCT required
• Timeline unknown (limited user data)
• Some report difficult recovery
• Uncertain recovery

Cardiovascular Side Effects

Side Effect 7: Cholesterol Disruption

The mechanism:

• Like all steroids, affects hepatic lipid metabolism
• HDL decreases
• LDL increases
• Atherogenic profile

Severity:

• Likely similar to other steroids
• Exact impact unknown (no studies)
• Presumed significant

Side Effect 8: Elevated Blood Pressure

The mechanisms:

• Water retention (estrogenic)
• Direct effects on vasculature
• Increased hematocrit possible
• Multiple pathways

The risk:

• Hypertension likely
• Degree unknown
• Cardiovascular concern

Side Effect 9: Cardiac Effects

The unknown:

• Long-term cardiac effects unstudied
• Left ventricular hypertrophy possible (like other steroids)
• Arterial stiffening possible
• Unknown long-term impact

The concern:

• No long-term human studies
• Cardiovascular risk presumed high
• Major unknown

Virilization in Women

The effects:

• All standard virilization effects
• Voice deepening
• Clitoral enlargement
• Facial/body hair
• Male pattern baldness
• Masculinization

The recommendation:

• Women should absolutely avoid MENT
• Even more so than other steroids (potency)
• Completely inappropriate

The Safety Concern: Experimental Status

The critical issue.

What We Don’t Know

Long-term effects:

• No studies beyond weeks/months
• Cardiovascular impact unknown
• Cancer risk unknown
• Organ toxicity unknown
• Complete uncertainty

Optimal dosing:

• No established guidelines
• Individual variation high
• Dose-response relationship unclear
• Guesswork

Interactions:

• With other drugs unknown
• With other steroids unclear
• Unknown combinations

Recovery:

• PCT efficacy unknown
• Natural testosterone recovery timeline unclear
• Permanent suppression risk unknown
• Recovery uncertain

The Quality Control Problem

Underground labs only:

• No pharmaceutical-grade MENT
• Purity unknown
• Dosing accuracy unknown
• Contamination possible
• No quality assurance

The risk:

• Underdosed: Ineffective, wasted money
• Overdosed: Excessive side effects, danger
• Contaminated: Unknown health risks
• Fake: Different compound entirely
• Product uncertainty

Testing:

• Can send to lab for testing (expensive)
• But most users don’t
• No guarantee even with testing
• Limited verification

The Informed Consent Issue

Can you truly consent?

• Informed consent requires knowing risks
• Risks largely unknown with MENT
• Not truly informed
• Ethical problem

The gamble:

• Using MENT = human experimentation on yourself
• No safety net
• No medical oversight (illegal)
• Unknown consequences
• High-stakes risk

Trestolone vs. Established Steroids

Is the risk justified?

MENT vs. Testosterone

Testosterone advantages:

• Decades of research
• Well-understood side effects
• Proven effective
• Pharmaceutical-grade available
• Medical protocols exist
• Known quantity

MENT theoretical advantages:

• Higher anabolic potency (less drug needed)
• Possibly less prostate enlargement
• Speculative benefits

MENT disadvantages:

• No long-term safety data
• Estrogen management more difficult
• Complete sperm suppression (fertility concern)
• No quality control
• Major unknowns

The verdict:

• Testosterone far safer choice
• MENT not worth risk for most users
• Testosterone preferred

MENT vs. Trenbolone

Trenbolone (also harsh but better studied):

• Extensive user experience
• Well-documented effects
• Known side effect profile
• No aromatization (easier estrogen control)
• More predictable

MENT claims:

• Less harsh than trenbolone
• Fewer side effects
• Marketing claims

The reality:

• MENT possibly less androgenic (prostate)
• But more estrogenic (gyno, water retention)
• Trade-offs, not clear superiority
• Trenbolone better understood
• Different, not better

MENT vs. Nandrolone

Nandrolone (closest structural relative):

• Well-studied
• Proven joint benefits
• Manageable side effects
• Pharmaceutical-grade available
• Established option

MENT claims:

• More anabolic than nandrolone
• Potency advantage possible

MENT problems:

• Heavy aromatization (nandrolone doesn’t aromatize much)
• Unknown long-term effects
• No quality control
• Safety disadvantage

The verdict:

• Nandrolone safer, more predictable
• MENT not worth extra risk
• Nandrolone preferred

The Honest Recommendation

Evidence-based guidance.

For First-Time Steroid Users

Absolutely avoid MENT:

• Not suitable for beginners
• Too many unknowns
• Start with testosterone only
• Never first choice

For Experienced Users

Extreme caution advised:

• Understand you’re experimenting on yourself
• No long-term safety data
• Quality control issues
• Recovery uncertainty
• High-risk proposition

If still considering:

• Start with lowest dose (10-15mg daily)
• Monitor bloodwork extensively (weekly initially)
• Have ancillaries ready (AI, PCT drugs)
• Accept unknown risks
• Document experience (for future reference)
• Harm reduction approach

Better alternatives:

• Testosterone: Well-studied, predictable
• Nandrolone: Proven, safer
• Even trenbolone: Better understood than MENT
• Established options preferable

The Risk-Benefit Analysis

Potential benefits:

• Possibly more anabolic than testosterone
• Possibly less prostate impact
• Speculative advantages

Definite risks:

• Unknown long-term effects
• Difficult estrogen management
• Complete fertility suppression
• No quality control
• Unknown recovery
• Experimental status
• Significant known and unknown risks

The conclusion:

• Risks outweigh potential benefits for vast majority
• Existing steroids provide proven results with known risk profiles
• MENT not worth the gamble
• Not recommended

---

This article is informational only. We do not condone or recommend steroid use, especially experimental compounds with unknown long-term effects. If considering any hormone therapy, work with qualified medical professionals and understand the serious health risks involved. Trestolone acetate carries unique risks due to its experimental status and lack of human safety data.

REFERENCES

SECTION 1 — Pharmacology and anabolic potency of MENT

[1] Kumar N et al. — PubMed/Journal of Steroid Biochemistry and Molecular Biology, 1999 Structure-activity study of 7α-methylated androgens; MENT demonstrated the highest androgen receptor binding affinity and in vitro bioactivity among all compounds tested, exceeding DHT, 19-nortestosterone, and testosterone; bioactivity correlated closely with AR binding affinity for 7α-substituted compounds; MENT’s high potency is primarily attributed to its elevated AR affinity; its bioavailability and metabolic clearance further shape its pharmacological profile in vivo; the foundational preclinical study establishing MENT’s exceptional anabolic receptor potency https://pubmed.ncbi.nlm.nih.gov/10704910/

[2] Sundaram K et al. — PubMed/Journal of Steroid Biochemistry, 1995 Preclinical comparison of MENT vs. testosterone in castrated rats; MENT’s effect on levator ani muscle (anabolic) was 10 times that of testosterone, while its effect on ventral prostate weight was only 4 times higher; a dose of MENT sufficient to maintain muscle mass and gonadotropin suppression did not maintain prostate and seminal vesicle weights, in contrast to testosterone; the differential tissue selectivity is explained by MENT’s resistance to 5α-reduction in the prostate; foundational data establishing MENT’s prostate-sparing anabolic activity and the preclinical basis for claims of tissue selectivity https://pubmed.ncbi.nlm.nih.gov/1597164/

[3] Attardi BJ et al. — PubMed/Journal of Andrology, 2011 Transactivation assay study confirming MENT was ten times more potent than testosterone and DHT in activating androgen receptor-driven gene expression; MENT was also as efficient as progesterone in activating progesterone receptor (PGR)-mediated expression; the aromatized metabolite 7α-methylestradiol demonstrated potent estrogenic activity via both estrogen receptor subtypes with efficiency comparable to natural estradiol; confirms the molecular basis for both MENT’s extreme anabolic potency and its significant estrogenic activity via aromatization to a uniquely potent estrogen https://pubmed.ncbi.nlm.nih.gov/22065861/

---

SECTION 2 — Aromatization, estrogenic metabolites, and differential metabolism

[4] Larrea F et al. — PubMed/Journal of Steroid Biochemistry, 1995 Mechanistic review of how differential tissue metabolism determines anabolic-to-androgenic ratios in 19-nor steroids; in prostate, testosterone is 5α-reduced to DHT, amplifying androgenic activity; MENT cannot undergo 5α-reduction due to steric hindrance from the 7α-methyl group, so its androgenic potency is not amplified in prostate tissue; anabolic potency in muscle remains unchanged; MENT is aromatized to 7α-methylestradiol by human placental and rat ovarian aromatase, suggesting some anabolic effects may be estrogen-mediated; explains why MENT causes significant estrogenic side effects despite its structural differences from testosterone https://pubmed.ncbi.nlm.nih.gov/7626464/

---

SECTION 3 — MENT pharmacokinetics and gonadotropin suppression in humans

[5] Suvisaari J et al. — PubMed/Human Reproduction, 1997 First pharmacokinetic and pharmacodynamic study of MENT by intramuscular injection in healthy men; peak MENT concentrations were dose-dependent and reached within 1-2 hours; daily injections produced a dose-dependent suppression of testosterone (−74%), LH (−70%), and FSH (−57%) at the highest dose; no adverse effects were detected during the study period; clearance rate was approximately 1,790 L/day, indicating rapid metabolism consistent with the short-acting acetate ester; confirms MENT’s extreme antigonadotrophic potency and rapid-onset suppression of the HPT axis in humans https://pubmed.ncbi.nlm.nih.gov/9194649/

[6] Anderson RA et al. — PubMed/Journal of Clinical Endocrinology and Metabolism, 1999 Phase I clinical trial examining MENT’s effects on sexual behavior and mood in 20 hypogonadal men (Edinburgh and Hong Kong); MENT implants maintaining plasma MENT of ~1.4 nmol/L produced equivalent improvements in sexual interest, erection, and mood to testosterone enanthate injections; no adverse toxicological effects detected during the 6-week treatment period; provides the only human clinical data directly comparing MENT to testosterone for androgen-replacement purposes; confirms androgenic activity in hypogonadal men but notes optimal dosing remains to be established https://pubmed.ncbi.nlm.nih.gov/10522995/

---

SECTION 4 — Suppression of spermatogenesis and fertility recovery following exogenous androgens

[7] Desai A et al. — PMC/Therapeutic Advances in Urology, 2022 Comprehensive review of HPT axis suppression caused by exogenous androgens and AAS; exogenous androgens suppress LH and FSH via negative feedback, reducing intratesticular testosterone to levels insufficient for spermatogenesis; recovery following cessation is highly variable and depends on baseline testicular function, duration of use, and age; meta-analysis data indicate approximately 90% of men reach sperm concentrations of 20 million/mL within 12 months of stopping testosterone-based hormonal contraception, but recovery in AAS users with prolonged exposure may require medical intervention; provides the evidence base for understanding MENT’s fertility suppression and the uncertainty of recovery following experimental use https://pmc.ncbi.nlm.nih.gov/articles/PMC9243576/